Vaccine Delivery Devices Market Report by Device (Syringes, Jet Injectors, and Others), Route of Administration (Intramuscular Vaccination, Intradermal Vaccination, Subcutaneous Vaccination, and Others), End User (Hospitals, Clinics, Others), and Region 2

Vaccine Delivery Devices Market Report by Device (Syringes, Jet Injectors, and Others), Route of Administration (Intramuscular Vaccination, Intradermal Vaccination, Subcutaneous Vaccination, and Others), End User (Hospitals, Clinics, Others), and Region 2024-2032

The global vaccine delivery devices market size reached US$ 7.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 13.5 Billion by 2032, exhibiting a growth rate (CAGR) of 6.61% during 2024-2032.

A vaccine is a biological substance used to protect individuals from bacterial illnesses by stimulating the immune response of the body against the disease. It helps the immune system to produce antibodies against the invading antigens when given at specific intervals. It can be delivered in the body through liposomes, microspheres, nanoparticles, dendrimers, micellar systems, immune stimulating complexes (ISCOMs), and plant-derived viruses. At present, there is a rise in the utilization of vaccine delivery devices due to the growing prevalence of infectious diseases across the globe.

Vaccine Delivery Devices Market Trends:
Technological advancements in the systematic delivery of vaccines, such as micro-needles and electroporation, represent one of the key factors driving the market. Moreover, there is an increase in the utilization of needle-free delivery systems as they decrease needle stick injuries and the vaccine antigen dose and enhance the vaccine immunogenicity. This, along with the rising research in the field of vaccines and the development of new vaccine delivery devices around the world, is propelling the growth of the market. In addition, governments of several countries are promoting immunization programs to prevent disabilities and deaths from vaccine-preventable diseases. This, coupled with the growing investments by non-governmental organizations (NGOs) for various vaccination programs and campaigns globally, is positively influencing the market. Besides this, key market players are focusing on novel delivery technologies that increase the therapeutic value of vaccines by reducing toxicity. Additionally, the expanding healthcare sector due to the increasing geriatric population and easy access to medical products and services is bolstering the market growth. Furthermore, the outbreak of coronavirus disease (COVID-19) is augmenting the sales of vaccine delivery devices worldwide.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global vaccine delivery devices market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on device, route of administration and end user.

Breakup by Device:

Syringes
Jet Injectors
Others

Breakup by Route of Administration:

Intramuscular Vaccination
Intradermal Vaccination
Subcutaneous Vaccination
Others

Breakup by End User:

Hospitals
Clinics
Others

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being 3M Company, Becton Dickinson and Company, Enesi Pharma Limited, Gerresheimer AG, INOVIO Pharmaceuticals, NanoPass, Panacea Biotec Pharma Limited (Panacea Biotec), Pharmajet Inc., Schott AG (Carl-Zeiss-Stiftung), Terumo Corporation and Vaxxas.

Key Questions Answered in This Report

1. What was the size of the global vaccine delivery devices market in 2023?
2. What is the expected growth rate of the global vaccine delivery devices market during 2024-2032?
3. What are the key factors driving the global vaccine delivery devices market?
4. What has been the impact of COVID-19 on the global vaccine delivery devices market?
5. What is the breakup of the global vaccine delivery devices market based on the device?
6. What is the breakup of the global vaccine delivery devices market based on the route of administration?
7. What is the breakup of the global vaccine delivery devices market based on end user?
8. What are the key regions in the global vaccine delivery devices market?
9. Who are the key players/companies in the global vaccine delivery devices market?